Hinge Health proven to deliver 3.0x ROI with the largest study of its kind
The study analyzed over 200,000 participants from nearly 1,000 employers over five years, finding $2,941 savings per member annually
Hinge Health, Inc. (NYSE:HNGE) today announced the results of the most comprehensive medical claims analysis of its digital musculoskeletal (MSK) solution, demonstrating an average cost savings of $2,941 per member per year using its chronic MSK program and a 3.0x ROI for employers and health plans.
With a rigorous methodology independently reviewed by Howden, a global leading benefits consultant, the study dwarfs all prior ROI studies in digital MSK. It analyzed claims data for more than 200,000 commercially-insured adults ages 18-64 across nearly 1,000 employers in 23 industries. Comparing Hinge Health members to a matched control group, the results are backed by scale, as well as long-term observation. The measurable outcomes show sustained savings over the course of five years from 2020 through 2024.
Key findings include:
- 3.0x ROI: Hinge Health clients saved an average of $2,941 per member per year on overall MSK medical costs, tripling the return on average program fees.
- Increasing returns YoY: The program's ROI has consistently increased since 2020, reaching 3.14x for 2024, reflecting the company's continued product innovation and deeper clinical engagement.
- Significant reductions in MSK service utilization: Hinge Health members had 69% fewer surgeries, 61% fewer injections, and 68% fewer imaging scans.
- Avoided surgeries drive savings: 52% of savings came from lower surgery costs after members managed pain with fewer surgical interventions.
Chronic MSK pain remains a leading cause of disability and healthcare costs in the United States. As medical claims for MSK conditions continue to rise, employers are increasingly focused on finding solutions that deliver measurable value.
"This study provides the most rigorous, large-scale evidence that digital MSK care delivers meaningful ROI for employers and health plans," said Dr. Jeffrey Krauss, Chief Medical Officer, Hinge Health. "By reducing members' need for expensive interventions like surgery and injections, we improve outcomes for the individual and reclaim spend for the employer."
Hinge Health's model has been validated six times by third-party firms since 2022, each pressure testing across different demographics, periods of time, and lines of business. This study further empowers benefits leaders to assess the economic advantages of using Hinge Health to manage rising MSK costs.
To view all Hinge Health clinical studies, visit our website.
About Hinge Health
Hinge Health's vision is to scale and automate the delivery of health care. Leveraging an AI-powered care model, wearable devices and access to expert clinicians, Hinge Health delivers personalized, evidence-based care that improves member outcomes and experiences while reducing costs for clients. The company is headquartered in San Francisco, California.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260603705980/en/
Media contact: media@hingehealth.com